-
Preparing for Disasters: Addressing Critical Obstetric and Gynecologic Needs of Patients: ACOG Committee Statement No. 15. Obstet. Gynecol. (IF 5.7) Pub Date : 2025-01-01
Large-scale catastrophic events, either natural or human-influenced, highlight the requisite for emergency plans that specifically address the needs of obstetric and gynecologic patients. Pregnant, postpartum, and lactating individuals and their newborns and infants can be adversely affected by disasters and disaster-related environmental conditions. Obstetrician-gynecologists and other health care
-
Infertility: Disparities and Access to Services: ACOG Committee Statement No. 14. Obstet. Gynecol. (IF 5.7) Pub Date : 2025-01-01
Diagnostic testing and treatment for infertility should be available to everyone in need of these services. The disparities in rates of infertility and the barriers to accessing assisted reproductive technology services should be understood through and addressed within a reproductive justice framework. Obstetrician-gynecologists and other health care professionals should identify specific populations
-
Urinary Tract Infections: An Age-Old Problem that Demands New Solutions. Obstet. Gynecol. (IF 5.7) Pub Date : 2025-01-01 Nazema Y Siddiqui
-
Home Visiting to Prevent Unintended Pregnancies. Obstet. Gynecol. (IF 5.7) Pub Date : 2025-01-01 Cristian I Meghea,Lee Anne Roman
-
Area Poverty and Adverse Birth Outcomes: An Opportunity for Quality Improvement. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-12 Nigel Madden,Samanvi Kanugula,Lynn M Yee,Kelsey Rydland,Joe Feinglass
OBJECTIVE To evaluate the association between area poverty and adverse birth outcomes in the diverse birthing population of a large health system. METHODS This was a retrospective cohort study using electronic health record and hospital administrative data for pregnant people at nine hospitals within a large health system in the Chicago metropolitan area from 2018 to 2023. Patient addresses were geocoded
-
Validity of a Classification System for the Levels of Maternal Care. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-12 Jennifer Vanderlaan,Jay Shen,Ian K McDonough
OBJECTIVE To assess the content validity of the classification of maternal level of care of the American Hospital Association Database for research use. METHODS This was a secondary data analysis where we classified the maternal level of care in the 2018 American Hospital Association Database and linked this to birth hospitalizations from five states in the 2016 and 2017 State Inpatient Databases:
-
Health Care Utilization After Immediate Compared With Delayed Postpartum Intrauterine Device Placement. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-12 Talis M Swisher,Amy Alabaster,Margaret C Howe
OBJECTIVE To investigate differences in health care utilization between immediate (within 10 minutes of placental delivery) and delayed (after 24 hours) intrauterine device (IUD) placement. METHODS This retrospective cohort study was conducted with data from Kaiser Permanente Northern California from 2017 to 2019 and included patients with an IUD placed between 0 and 63 days postpartum. The primary
-
Blood Pressure in Pregnancy and Hypertension 10-14 Years After Delivery. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-12 Kartik K Venkatesh,William A Grobman,Jiqiang Wu,Maged M Costantine,Mark B Landon,Denise Scholtens,William Lowe,Nilay S Shah,Natalie A Cameron,Sadiya S Khan
We examined the association between blood pressure (BP) in the early third trimester and hypertension 10-14 years after delivery per American College of Cardiology and American Heart Association recommendations. We conducted a secondary analysis using the prospective HAPO FUS (Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study) in patients without a chronic hypertension diagnosis. The exposure
-
Addressing the Menopause Health Needs of Military Service Members: A Call to Action. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-05 Jill Brown,Katerina Shvartsman,Jezreelyn Bulaklak,Catherine Witkop,Monica Lutgendorf
The menopause transition represents a significant life phase for people assigned female at birth marked by various physical and psychological changes. For military service members and veterans, this transition can be even more complex because of unique factors related to military service. A tradition of excluding women from service before reaching the age of the menopause transition has left the Military
-
Online Screening and Virtual Patient Education for Hereditary Cancer Risk Assessment and Testing. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-05 Richard N Waldman,Mark S DeFrancesco,John P Feltz,Daniel S Welling,Wade A Neiman,Melissa M Pearlstone,Christine A Marraccini,Dana Karanik,Elaine Mielcarski,Logan Schneider,Lauren Lenz,Edith C Smith,Katherine Johansen Taber,Royce T Adkins
OBJECTIVE To use online screening and virtual patient education tools to improve the provision of hereditary cancer risk assessment. METHODS We conducted a prospective, single-arm study in which clinicians at five U.S. community obstetrics and gynecology practices underwent an 8-week observation followed by 3-4 weeks of training on online patient screening and virtual patient education (prerecorded
-
Treatment of Early Pregnancy Loss With Mifepristone and Misoprostol Compared With Misoprostol Only. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-05 Matan Friedman,Liat Mor,Rotem Shazar,Natalie Paul,Ram Kerner,Ran Keidar,Ron Sagiv,Ohad Gluck
OBJECTIVE To compare the rates of treatment failure in cases of early pregnancy loss between mifepristone-misoprostol and misoprostol only. METHODS This retrospective cohort study included patients who received medical treatment for early pregnancy loss between 2016 and 2023 at a single medical center. Patients returned for a follow-up ultrasonogram after 1 week and were treated again with misoprostol
-
Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autistic Spectrum Disorder. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-05 Per Damkier,Erika B Gram,Michael Ceulemans,Alice Panchaud,Brian Cleary,Christina Chambers,Corinna Weber-Schoendorfer,Debra Kennedy,Ken Hodson,Kimberly S Grant,Orna Diav-Citrin,Sarah G Običan,Svetlana Shechtman,Sura Alwan
Acetaminophen is a common over-the-counter medication that recently gained substantial media attention regarding its use by pregnant individuals. In this clinical perspective, we discuss the strengths and limitations of the published literature on the effect of maternal acetaminophen use in pregnancy on the child's risk of developing attention-deficit and hyperactivity disorder (ADHD) and autistic
-
The Maryland Infertility Mandates: Firsts Across the Board. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-05 Eli Y Adashi,Howard Haft
-
ACOG Committee Statement No. 13: Self-Managed Abortion. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-01
Self-managed abortion (SMA) refers to actions people take to end a pregnancy outside the formal health care system. There are a variety of reasons people choose to self-manage their abortions, and these reasons may vary based on regional contexts. For some people, medically delivered abortion care is no longer, or has never been, available in their community. Available options might be inaccessible
-
Management of Red Cell Alloimmunization in Pregnancy: Correction. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-01
-
ACOG Committee Statement No. 12: Health Care for Women and Gender-Diverse Active-Duty and Reserve Uniformed Service Members and Veterans. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-01
An increasing percentage of the active-duty and reserve uniformed services force are women, and they are the fastest growing population in the Veterans Health Administration (VHA). Additionally, the VHA is one of the largest providers of gender-affirming care in the United States. Asking about a patient's military service and being aware of the unique health and reproductive health care needs of this
-
ACOG Clinical Consensus No. 4: Urinary Tract Infection in Pregnant Individuals: Correction. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-01
-
Hysterectomy at a Young Age: A Reasonable Option or a Recipe for Regret? Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-01 Olga Bougie
-
Antenatal Corticosteroid Administration for Patients at Risk for Late Preterm Delivery: Shared Decision-Making, Individualizing Risk, and Centering Patient Values. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-12-01 Sarah S Osmundson,Justin R Lappen
-
Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-26 Marisa Gilstrop Thompson,Wenbo Xu,Bridget Moore,Tina Wang,Nicholas Sun,Hemant Pewar,Neil D Avent,Abelardo Vernaza,Felipe Acosta,Jessica L Saben,Vivienne Souter,Sheetal Parmar,Urmi Sengupta,Yucel Altug,Joshua EmBree,Carlos Cantos,Chitra Kotwaliwale,Joshua Babiarz,Bernhard Zimmermann,Ryan Swenerton,Jeffrey T Meltzer
OBJECTIVE To present a large U.S. clinical validation of a next-generation sequencing-based, noninvasive prenatal cell-free DNA test for fetal RHD. METHODS This clinical validation study assessed the performance of a commercially available, next-generation sequencing-based cell-free DNA test for fetal RHD status. Samples that passed quality metrics were included if the patient had a previously reported
-
Transcutaneous Electric Nerve Stimulation for Analgesia During Outpatient Endometrial Biopsy: A Randomized Controlled Trial. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-21 Jenny Wu,Stephanie Lim,Amelia Scott,Taylor Hayes,Shakthi Unnithan,Alaattin Erkanli,Laura J Havrilesky,Jonas J Swartz
OBJECTIVE To evaluate whether transcutaneous electric nerve stimulation (TENS) decreases pain at the time of outpatient endometrial biopsy. METHODS We conducted a randomized, double-blind trial of active TENS compared with placebo TENS at the time of endometrial biopsy. The primary outcome was pain measured on a 0- to 100-mm visual analog scale immediately after biopsy, with secondary outcomes including
-
Effect of an Intensive Nurse Home Visiting Program on Postpartum Contraceptive Use and Birth Spacing: A Randomized Controlled Trial. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-14 Maria W Steenland,Dea Oviedo,Mary Ann Bates,Annetta Zhou,Chloe Zera,Katherine Baicker,Margaret A McConnell
OBJECTIVE To evaluate the effect of an intensive nurse home visiting program on postpartum contraceptive use and birth spacing among individuals with a first pregnancy who were eligible for Medicaid insurance in South Carolina. METHODS We conducted a nonblinded, randomized controlled trial of the Nurse-Family Partnership (NFP), an established intensive home visiting program that provides prenatal and
-
Effects of Routine Catheterization on Urinary Tract Infection Rates After Minor Gynecologic Surgeries. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-14 Salina Zhang,Deepasri Ananth,Lyn Haselton,Jenifer Byrnes
This pilot study describes urinary tract infection (UTI) rates after routine single catheterization during minor gynecologic surgeries at a tertiary care community hospital. Records from 762 patients from 2021 were reviewed, including procedures such as hysteroscopy, loop electrosurgical excision procedure, and dilation and curettage. Findings revealed a 42.4% catheterization rate, with a significantly
-
Management of Full-Term Nulliparous Individuals Without a Medical Indication for Delivery: ACOG Clinical Practice Update. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-07
This Clinical Practice Update integrates data from a large, randomized controlled trial (the ARRIVE trial [A Randomized Trial of Induction Versus Expectant Management]) and subsequent other related studies into existing American College of Obstetricians and Gynecologists' guidance regarding management of pregnant individuals at 39 0/7-41 6/7 weeks of gestation without a medical indication for delivery
-
Optimization of Timing for Risk-Reducing Salpingectomy and Oophorectomy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-07 Kathryn P Pennington,Stephanie L Pugh,Warner Huh,Joan L Walker,Elizabeth Jewell,Laura J Havrilesky,Jeanne Carter,Carolyn Y Muller,Ronny Drapkin,Heather A Lankes,Tara Castellano,Abigail S Zamorano,Stephanie V Blank,Lisa A Kachnic
ClinicalTrials.gov , NCT04251052.
-
Trends in Short Interpregnancy Interval Births in the United States, 2016-2022. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-07 Lindsay K Admon,Colleen MacCallum-Bridges,Jamie R Daw
OBJECTIVE To measure contemporary trends in the prevalence of short interpregnancy interval (IPI) births in the United States. METHODS We conducted a repeated cross-sectional analysis using 2016-2022 natality data from the National Vital Statistics System. We included all singleton live births to individuals with at least one prior live birth. We examined trends over time in short IPIs less than 18
-
Delivery-Related Maternal Morbidity and Mortality Among Patients With Cardiac Disease. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-07 Isabella Toledo,Heather Czarny,Emily DeFranco,Carri Warshak,Robert Rossi
OBJECTIVE To assess the risk of severe maternal morbidity (SMM) and mortality among pregnant patients with cardiovascular disease (CVD). METHODS This was a retrospective cohort study of U.S. delivery hospitalizations from 2010 to 2020 using weighted population estimates from the National Inpatient Sample database. The primary objective was to evaluate the risk of SMM and maternal mortality among patients
-
Effects of the Affordable Care Act on Contraception, Pregnancy, and Pregnancy Termination Rates. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-01 Matthew D Solomon,Eve F Zaritsky,Margaret Warton,Andrea Millman,Ashley Huynh,Bharathi Chinnakotla,Mary E Reed
OBJECTIVE To investigate the effects of the Affordable Care Act (ACA) and its elimination of cost-sharing on contraception utilization, pregnancy rates, and abortion rates. METHODS We conducted a retrospective cohort study within a healthcare system serving over 4.5 million insured members across 21 medical centers and 250 clinics. The study included women aged 18-45 with continuous health plan membership
-
Trends in Urinary Tract Infection Management in Women. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-01 Ghanshyam S Yadav,Heidi W Brown,Shawn A Menefee,Su-Jau Yang,Jasmine Tan-Kim
Urinary tract infections (UTIs) are a common cause of health care utilization in the United States. The coronavirus disease 2019 (COVID-19) pandemic accelerated virtual care for UTIs. This retrospective cohort study analyzes more than 1.2 million encounters for UTI based on diagnosis codes, examining temporal trends focusing on virtual compared with in-person encounters, antibiotic dispensation rates
-
Challenging the American College of Obstetricians and Gynecologists' Clinical Practice Update on Screening for Pre-existing Diabetes and Early Gestational Diabetes. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-31 Kent D Heyborne,Linda A Barbour
A recent American College of Obstetricians and Gynecologists Clinical Practice Update continues to recommend targeted (as opposed to universal) screening for pregestational diabetes, no longer recommends screening for early gestational diabetes mellitus (GDM), and provides updated guidelines for immediate postpartum testing for diabetes in patients with GDM. Here, we present data that the targeted
-
Development of a Practical Prediction Model for Adverse Neonatal Outcomes at the Start of the Second Stage of Labor. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-31 Mark A Clapp,Siguo Li,Kaitlyn E James,Emily S Reiff,Sarah E Little,Thomas H McCoy,Roy H Perlis,Anjali J Kaimal
OBJECTIVE To develop a prediction model for adverse neonatal outcomes using electronic fetal monitoring (EFM) interpretation data and other relevant clinical information known at the start of the second stage of labor. METHODS This was a retrospective cohort study of individuals who labored and delivered at two academic medical centers between July 2016 and June 2020. Individuals were included if they
-
Effects of Social Determinants of Health and Social Support on Surgical Outcomes Among Patients Undergoing Hysterectomy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-31 Adam M Hare,Erryn Tappy,Joseph I Schaffer,Kelsey Kossl,Bertille Gaigbe-Togbe,Anjani Kapadia,Alexis A Dieter,Jennifer Hamner,Amanda K Laporte,Tsung Mou,Margaret G Mueller,Josephine Doo,Amy J Park,Graham C Chapman,Gina Northington,Marie Shockley,Cheryl B Iglesia,Michael Heit
OBJECTIVE To describe composite 30-day postoperative complication rates among patients undergoing hysterectomy during the coronavirus disease 2019 (COVID-19) pandemic and to determine baseline and postoperative mental health symptoms, levels of social support, and socioeconomic status and their association with hysterectomy outcomes. METHODS This multicenter prospective cohort study at eight centers
-
Effectiveness of the Intrauterine Balloon Tamponade Compared With an Intrauterine, Vacuum-Induced, Hemorrhage-Control Device for Postpartum Hemorrhage. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-24 Laurence E Shields,Catherine Klein,Jennie Torti,Mindy Foster,Curtis Cook
OBJECTIVE To compare intrauterine balloon tamponade and vacuum-induced hemorrhage-control devices in a multicenter hospital system using a standardized three-stage postpartum hemorrhage response algorithm. METHODS As part of a quality improvement project, data were prospectively collected through ongoing detailed hemorrhage case audits from 65 facilities from August 2022 to February 2024. Postpartum
-
Outcomes for Female Physicians Compared With Nonphysicians After Assisted Reproductive Technology. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-24 Anna C Vanderhoff,Andrea Lanes,Rachel Herz-Roiphe,Keizra Mecklai,Oscar Leyva Camacho,Serene S Srouji,Sarah Rae Easter,Janis Fox,Erika L Rangel
OBJECTIVE To evaluate outcomes of female physicians after assisted reproductive technology (ART). METHODS We conducted a retrospective cohort study using data from 248 physician patients and 3,470 nonphysician patients who underwent a total of 10,095 fresh or frozen ART cycles at a single academic center in an insurance-mandated state between January 2015 and March 2022. The primary outcome was live-birth
-
Association of Central and General Obesity Measures With Pelvic Organ Prolapse. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-24 Keyi Si,Yingying Yang,Qianqian Liu,Qin Wang,Shaohua Yin,Qingqiang Dai,Yuting Yao,Lei Yuan,Guizhu Wu
OBJECTIVE To examine the association between the combination of central and general obesity measures and the risk of pelvic organ prolapse (POP). METHODS Waist/height ratio and body mass index (BMI, calculated as weight in kilograms divided by height in meters squared) for 251,143 participants (aged 39-71 years) without pre-existing POP from the UK Biobank were collected at enrollment between 2006
-
Changes in Availability of Later Abortion Care Before and After Dobbs v. Jackson Women's Health Organization. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-24 Nancy F Berglas,Rosalyn Schroeder,Shelly Kaller,Clara Stewart,Ushma D Upadhyay
OBJECTIVE To examine changes in availability of procedural abortion, especially in the second and third trimesters of pregnancy, since the U.S. Supreme Court ended federal protections for abortion in its Dobbs v. Jackson Women's Health Organization decision in 2022. METHODS We used the Advancing New Standards in Reproductive Health Abortion Facility Database, a national database of all publicly advertising
-
Addressing Social and Structural Determinants of Health in the Delivery of Reproductive Health Care: ACOG Committee Statement No. 11. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-01
Social and structural determinants of health include historical, social, political, and economic forces, many of which are rooted in racism and inequality, that shape the relationship between environmental conditions and individual health. Unmet social needs can increase the risk of many conditions treated by obstetrician-gynecologists (ob-gyns), including, but not limited to, preterm birth, unintended
-
Symptom Resolution After Operative Management of Complications From Transvaginal Mesh: Notice of Update. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-01
-
Diabetic Ketoacidosis in Pregnancy: A Call to Eliminate Preventable Complications. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-01 Chloe Zera
-
A Tribute to John T. Queenan, MD (1933-2024). Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-11 James R Scott
-
Age to Initiate Routine Breast Cancer Screening: ACOG Clinical Practice Update. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-11
This Clinical Practice Update provides revised guidance on the age to start routine breast cancer screening with mammography. This document is a focused update of related content in Practice Bulletin No. 179 , Breast Cancer Risk Assessment and Screening in Average-Risk Women (Obstet Gynecol 2017;130:e1-16).
-
Combining Ultrasonography and Endometrial Aspiration as a One-Stop Screening for Endometrial Neoplasia. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-10 Ohad Rotenberg,Georgios Doulaveris,Gary L Goldberg,Malte Renz,Kathleen Whitney,Leeann Dar,Noam Rotenberg,Haotian Wu,Thierry Van den Bosch,Pe'er Dar
OBJECTIVE To assess the performance of simultaneous endometrial aspiration and sonohysterography to screen for endometrial cancer or hyperplasia in women aged 50 years or older. METHODS We conducted a prospective study from February 2014 to October 2020 at the ultrasound unit of a large urban academic medical center. The study included 1,635 women aged 50 years or older referred for endometrial evaluation
-
Betamethasone Exposure and Neonatal Respiratory Morbidity Among Late Preterm Births by Planned Mode of Delivery and Gestational Age. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-10 Mark A Clapp,Siguo Li,Jessica L Cohen,Cynthia Gyamfi-Bannerman,Amy B Knudsen,Scott A Lorch,Tanayott Thaweethai,Jason D Wright,Anjali J Kaimal,Alexander Melamed
OBJECTIVE To estimate the effect of late preterm antenatal steroids on the risk of respiratory morbidity among subgroups of patients on the basis of the planned mode of delivery and gestational age at presentation. METHODS This was a secondary analysis of the ALPS (Antenatal Late Preterm Steroid) Trial, a multicenter trial conducted within the Eunice Kennedy Shriver National Institute of Child Health
-
Late-Onset Postpartum Hypertension After Normotensive Pregnancy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-03 Colleen Sinnott,Lisbet Lundsberg,Jennifer Culhane,Caitlin Partridge,Anna E Denoble
To better inform efforts to improve and extend postpartum care, we sought to estimate the incidence of de novo hypertension up to 6 months postpartum in patients without evidence of hypertension during pregnancy or immediately postpartum. This retrospective cohort study included all patients delivering within an academic health care system. All blood pressure (BP) measurements from fertilization to
-
Screening Characteristics of Hemoglobin and Mean Corpuscular Volume for Detection of Iron Deficiency in Pregnancy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-03 Hui Xiao Chao,Travis Zack,Andrew D Leavitt
Iron deficiency in pregnancy remains underdiagnosed despite professional society recommendations for first-trimester complete blood count (CBC) screening. To determine the effectiveness of the CBC hemoglobin and mean corpuscular volume (MCV) to identify iron deficiency in pregnancy, we conducted a retrospective analysis of 20,550 pregnancies from 2009 to 2022 at the University of California, San Francisco
-
A New Tool for Estimating the Number of Pregnant People in the United States. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-03 Penelope Strid,Regina M Simeone,Rebecca Hall,Jessica R Meeker,Sascha R Ellington
BACKGROUND Knowing the approximate number of women of reproductive age (ie, 15-49 years) who are pregnant at a point in time in the United States can aid in emergency preparedness resource allocation. The Centers for Disease Control and Prevention (CDC) released a pregnancy estimator toolkit in 2012, which could be used to estimate the number of pregnant people in a geographic area at a point in time
-
Association Among Surgeon Volume, Surgical Approach, and Uterine Size for Hysterectomy for Benign Indications. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-03 Sarah Santiago,Darington Richardson,Neil Kamdar,Sara R Till,Sawsan As-Sanie,Christopher X Hong
OBJECTIVE To assess the relationship between surgeon volume and surgical approach for patients undergoing hysterectomy for benign indications among uteri of varying sizes. METHODS This was a retrospective cohort study of patients who underwent hysterectomy for benign indications from 2012 to 2021 within the Michigan Surgical Quality Collaborative registry. For each hysterectomy, the relative annual
-
Sexual Orientation-Related Disparities in Neonatal Outcomes. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-03 Payal Chakraborty,Colleen A Reynolds,Sarah McKetta,Kodiak R S Soled,Aimee K Huang,Brent Monseur,Jae Downing Corman,Juno Obedin-Maliver,A Heather Eliassen,Jorge E Chavarro,S Bryn Austin,Bethany Everett,Sebastien Haneuse,Brittany M Charlton
OBJECTIVE To evaluate whether disparities exist in adverse neonatal outcomes among the offspring of lesbian, gay, bisexual, and other sexually minoritized (LGB+) birthing people. METHODS We used longitudinal data from 1995 to 2017 from the Nurses' Health Study II, a cohort of nurses across the United States. We restricted analyses to those who reported live births (N=70,642) in the 2001 or 2009 lifetime
-
Updates in Prevention, Detection, and Management of Alloimmunized Pregnancies. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-01 Teresa N Sparks,Kathryn J Gray
-
Excellent Performance of a Brief Self-Screening Tool for Medication Abortion Eligibility May Give Patients More Options. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-01 Stephanie Teal
-
Oocyte Cryopreservation in Transgender and Gender-Diverse Individuals With or Without Prior Testosterone Use. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-26 Sarah Capelouto Cromack,Jessica R Walter,Kristin N Smith,Jennifer Elvikis,Sarah E Bazzetta,Kara N Goldman
To evaluate oocyte cryopreservation among transgender and gender-diverse adolescents and young adults with or without prior testosterone exposure, we performed a retrospective cohort study of all patients younger than age 35 years referred for oocyte cryopreservation through our formal fertility-preservation program from 2014 to 2023. The number of patients referred and pursuing fertility preservation
-
Second-Line Uterotonics for Uterine Atony: A Randomized Controlled Trial. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-26 Naida M Cole,Jimin J Kim,Mario I Lumbreras-Marquez,Kara G Fields,Laura Mendez-Pino,Michaela K Farber,Daniela A Carusi,Paloma Toledo,Brian T Bateman
OBJECTIVE To evaluate the comparative efficacy of two of the most commonly used second-line uterotonics-methylergonovine maleate and carboprost tromethamine. METHODS We conducted a double-blind randomized trial at two large academic perinatal centers in patients undergoing nonemergency cesarean delivery with uterine atony refractory to oxytocin, as diagnosed by the operating obstetrician. The intervention
-
Survival After Simple Compared With Radical Hysterectomy for Patients With Early-Stage Cervical Cancer. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-26 David Viveros-Carreño,Nuria Agusti,Chi-Fang Wu,Alexander Melamed,Roni Nitecki Wilke,Alexa Kanbergs,René Pareja,Abigail S Zamorano,J Alejandro Rauh-Hain
OBJECTIVE To assess the effect on overall survival of simple hysterectomy with lymph node staging compared with radical hysterectomy with lymph node staging for patients with early-stage cervical cancer. METHODS We conducted a retrospective cohort study of patients in the National Cancer Database diagnosed with early cervical carcinoma of 2 cm or smaller (stage IA1 with lymphovascular space invasion
-
Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-19 Kimberly A Moyle,D Ware Branch,Lisa K Peterson,Marta M Guerra,Amanda A Allshouse,Ashley E Benson,Jane E Salmon
OBJECTIVE To investigate the value of anti-β2 glycoprotein-I domain 1 (aD1) and antiphosphatidylserine-prothrombin antibodies for predicting adverse pregnancy outcomes in an at-risk population and to describe the relationship among aD1, antiphosphatidylserine-prothrombin, lupus anticoagulant, and other antiphospholipid antibodies (aPL). METHODS Data were obtained from a prospective cohort of pregnant
-
Pregnancy in People With Cystic Fibrosis Treated With Highly Effective Modulator Therapy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-19 Jennifer L Goralski,Asha N Talati,Emily E Hardisty,Neeta L Vora
With improvements in overall health attributable to newly available medications called highly effective modulator therapy, an increasing number of people with cystic fibrosis (CF) are pursuing pregnancy. However, the safety of these medications for pregnant people with CF and the fetus remains largely unknown. Limited data demonstrate a decline in patients' health and well-being after withdrawal of
-
Effect of Patient Age on Decisional Regret After Laparoscopic Hysterectomy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-19 Nathan R King,Alison M Zeccola,Li Wang,John A Harris,Christine E Foley
OBJECTIVE To compare long-term decision regret between younger (30 years or younger) and older (31-49 years) patients who underwent laparoscopic hysterectomy for benign disease. METHODS We conducted a matched retrospective cohort study to analyze patients who underwent laparoscopic hysterectomies for benign indications from 2009 to 2016. Respondents completed surveys including two validated decision
-
Trends in Uterine Cancer Cases After the Coronavirus Disease 2019 (COVID-19) Pandemic. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-19 Nathan Tran,Joshua E Chan,Chelsea Stewart,Caitlin R Johnson,Kathleen Darcy,Chunqiao Tian,Daniel S Kapp,Cheng-I Liao,John K Chan
We assessed the temporal trends in diagnosis of uterine cancer before and during the coronavirus disease 2019 (COVID-19) pandemic using data from the United States Cancer Statistics database spanning from 2001 to 2020. A comparison between projected and observed new cases in 2020 revealed a 4,232-case discrepancy, indicating 9.3% fewer diagnosed cases than predicted based on trends. Hispanic and Asian
-
False-Positive Human Immunodeficiency Virus-1 Test Results With Rapid Seroreversion After Third-Trimester Tdap Booster Vaccination. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-16 Karl O A Yu,Seth R Glassman,Heather M Link
BACKGROUND False-positive and false-negative results in human immunodeficiency virus (HIV) testing are expected at some frequency. False-positive results have been reported in association with various conditions, including pregnancy, autoimmune disease, and infection. We present an atypical case of a pregnant patient receiving false-positive HIV results for both screening and antibody confirmatory
-
Effects of Antihypertensive Therapy During Pregnancy on Postpartum Blood Pressure Control. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-01 Samantha L Martin,Hui-Chien Kuo,Kim Boggess,Lorraine Dugoff,Baha Sibai,Kirsten Lawrence,Brenna L Hughes,Joseph Bell,Kjersti Aagaard,Kelly S Gibson,David M Haas,Lauren Plante,Torri D Metz,Brian M Casey,Sean Esplin,Sherri Longo,Matthew Hoffman,George R Saade,Janelle Foroutan,Methodius G Tuuli,Michelle Y Owens,Hyagriv N Simhan,Heather A Frey,Todd Rosen,Anna Palatnik,Susan Baker,Phyllis August,Uma M Reddy
OBJECTIVE To compare differences in postpartum blood pressure (BP) control (BP below 140/90 mm Hg) for participants with hypertension randomized to receive antihypertensive treatment compared with no treatment during pregnancy. METHODS This study was a planned secondary analysis of a multicenter, open-label, randomized controlled trial (The CHAP [Chronic Hypertension and Pregnancy] trial). Pregnant
-
Tamsulosin and Time to Spontaneous Void After Hysterectomy: A Randomized Controlled Trial. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-12 Martina Gabra,Christine Hall,Lelan McCann,Jeenal Shah,Ismael Jones,Aaron Masjedi,Stephanie Runke,Chiu-Hsieh Hsu,Andrea Aguirre
OBJECTIVE To evaluate whether a single preoperative dose of tamsulosin reduces the time to postoperative void and time to discharge in patients who are undergoing minimally invasive hysterectomy. METHODS This single-center, block-randomized, placebo-controlled, double-blind superiority trial evaluated the effect of 0.4 mg tamsulosin compared with placebo on the time to void after hysterectomy. Patients